Immune Therapeutics, Inc. announced that effective January 13, 2015, Dr. Eugene Youkilis is stepping down from the position of President of Immune Therapeutics, Inc., but will continue to serve as a member of the board of directors of the company. Effective January 13, 2015, Christopher Pearce is stepping down from the position of Chief Operating Officer of the company, but will continue to serve as a member of the board of directors of the company. Effective January 13, 2015, the board of directors of the company formally appointed Seth Elliott as President and Chief Operating Officer of the company.

Mr. Elliot has spent more than 15 years as a founder or senior executive of emerging growth and middle market enterprises. He has helped to accelerate corporate growth in diverse markets, on behalf of a variety of companies through economic conditions ranging from boom to bust, developing a rare combination of experience, vision, leadership and business intuition. Mr. Elliott started his position as Chief Strategy Officer of Engagement Media Technologies in 2011.